文献速递哮喘

重症哮喘关键预后因素的交互通路:临床试验与真实世界数据的贝叶斯网络比较

Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials and Real-World Data.
PubMed 文献 · Chest · 2026-01-24

本研究以2项国际随机对照试验安慰剂组345例重症哮喘患者与ISAR注册库6814例生物制剂初治患者为对象,用贝叶斯网络比较导致重症哮喘急性发作的风险预测因素交互通路。结果显示RCT有44条显著弧、ISAR有170条,但核心下游预测通路一致,均包括总血清IgE经血嗜酸性粒细胞预测未来发作及既往重症发作史直接预测未来发作。外部验证中RCT-BN在ISAR患者中AUC为0.68,ISAR-BN在RCT患者中AUC为0.50且校准更优。

要点

  • RCT与真实世界核心预测通路一致:IgE经血嗜酸性粒细胞及既往发作史预测未来重症发作。
  • RCT-BN外部验证AUC 0.68,ISAR-BN在RCT患者中AUC 0.50但校准更好。
  • 真实世界风险因素间概率依赖关系更多(ISAR 170条 vs RCT 44条)。

核心结论

  • RCT与真实世界环境中预测重症哮喘急性发作的核心通路相似,预测性能相当。

研究设计与样本

  • 比较2项国际RCT安慰剂组345例重症哮喘患者与ISAR注册库6814例生物制剂初治患者。
  • 纳入16个关键风险预测因素,结局为入组后365天内重症哮喘急性发作。
  • 采用机器学习结合专家知识构建贝叶斯网络,并在各队列进行外部验证。

主要发现

  • RCT显示16个风险因素间44条显著弧,ISAR显示170条。
  • 主要下游预测通路一致:总血清IgE影响血嗜酸性粒细胞以预测未来重症发作。
  • 另一核心通路为既往重症发作史直接预测未来重症发作。
  • 外部验证RCT-BN在ISAR患者中AUC为0.68。
  • ISAR-BN在RCT患者中AUC为0.50,且ISAR-BN校准更优。

临床怎么用

  • 可关注总血清IgE与血嗜酸性粒细胞通路及既往重症发作史用于重症哮喘风险分层。
  • 真实世界模型校准更优但跨环境预测性能有限,应用时需结合本地数据验证。

局限性

  • RCT样本来自安慰剂组,可能限制向其他治疗人群外推。
  • ISAR-BN在RCT患者中AUC仅0.50,跨环境判别能力不足。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The way in which risk predictors combine and contribute to severe asthma exacerbations may differ between clinical trials and real-world settings. RESEARCH QUESTION: How do the interactive pathways of risk predictors leading to severe asthma exacerbations compare under clinical trials vs real-world settings? STUDY DESIGN AND METHODS: The analysis involved 345 patients with severe asthma from the placebo arms of 2 international randomized controlled trials (RCTs), compared with 6,814 biologic-naïve patients from the International Severe Asthma Registry (ISAR). Sixteen key risk predictors, including demographics, biomarkers, lung function, health care use, exacerbation history, long-term oral corticosteroid use, asthma control, and nasal polyps, were covered. The outcome was the occurrence of severe asthma exacerbations over the 365 days after study enrollment. Bayesian networks (BNs), obtained from machine learning combined with expert knowledge, elucidated significant interplay processes of risk predictors that led to severe asthma exacerbations. External validation was performed in each cohort. RESULTS: The RCTs revealed 44 significant arcs (ie, probabilistic interdependency) between 16 risk factors, whereas the ISAR showed 170. Despite this difference, the main downstream prediction pathways were consistent across both settings, with 2 key pathways: total serum IgE level influenced blood eosinophils to predict future severe exacerbations, and severe exacerbation history directly predicted future severe exacerbations. In external validation, RCT-BN generalized well to ISAR patients (area under the receiver operating characteristic curve, 0.68), whereas ISAR-BN underperformed in RCT patients (area under the receiver operating characteristic curve, 0.50), and ISAR-BN demonstrated better calibration. INTERPRETATION: Our results show that the core pathways predicting severe asthma exacerbations were similar in both RCTs and real-world settings, with comparable predictive performance.

来源:Chest,查看原文。版权归原作者所有。

引用

  1. Yadav, Lim, Price, et al. Interactive Pathways of Key Prognostic Factors in Severe Asthma: A Bayesian Network Comparison of Clinical Trials and Real-World Data. Chest. 2026. PMID: 41587637. doi:10.1016/j.chest.2026.01.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。